These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 16551870)
41. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253 [TBL] [Abstract][Full Text] [Related]
42. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis. Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156 [TBL] [Abstract][Full Text] [Related]
43. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
44. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666 [TBL] [Abstract][Full Text] [Related]
45. Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. Mayor R; Muñoz M; Coolen MW; Custodio J; Esteller M; Clark SJ; Peinado MA Epigenetics; 2011 Sep; 6(9):1138-48. PubMed ID: 21852760 [TBL] [Abstract][Full Text] [Related]
46. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
47. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228 [TBL] [Abstract][Full Text] [Related]
48. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. Hinoi T; Loda M; Fearon ER J Biol Chem; 2003 Nov; 278(45):44608-16. PubMed ID: 12947088 [TBL] [Abstract][Full Text] [Related]
49. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980 [TBL] [Abstract][Full Text] [Related]
50. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418 [TBL] [Abstract][Full Text] [Related]
51. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
52. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Bhakat KK; Mitra S Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730 [TBL] [Abstract][Full Text] [Related]
53. DNA methylation in the upstream CpG island of the GPER locus and its relationship with GPER expression in colon cancer cell lines. Pal U; Ghosh S; Limaye AM Mol Biol Rep; 2020 Oct; 47(10):7547-7555. PubMed ID: 32936384 [TBL] [Abstract][Full Text] [Related]
54. Relationship between the expression of CES2, UGT1A1, and GUSB in colorectal cancer tissues and aberrant methylation. Xie FW; Peng Y; Chen X; Chen X; Li J; Wang W; Yu Z; Ouyang X Neoplasma; 2014; 61(1):99-109. PubMed ID: 24195516 [TBL] [Abstract][Full Text] [Related]
55. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon. Cummings J; Ethell BT; Jardine L; Burchell B Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585 [TBL] [Abstract][Full Text] [Related]
56. Histone Modifications Regulate the Developmental Expression of Human Hepatic UDP-Glucuronosyltransferase 1A1. Nie YL; Meng XG; Liu JY; Yan L; Wang P; Bi HZ; Kan QC; Zhang LR Drug Metab Dispos; 2017 Dec; 45(12):1372-1378. PubMed ID: 29025858 [TBL] [Abstract][Full Text] [Related]
57. PAQR4 oncogene: a novel target for cancer therapy. Patil D; Raut S; Joshi M; Bhatt P; Bhatt LK Med Oncol; 2024 May; 41(6):161. PubMed ID: 38767705 [TBL] [Abstract][Full Text] [Related]
58. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. Madkour MM; Ramadan WS; Saleh E; El-Awady R Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854 [TBL] [Abstract][Full Text] [Related]
59. The Glycosyltransferase Pathway: An Integrated Analysis of the Cell Metabolome. Audet-Delage Y; Rouleau M; Villeneuve L; Guillemette C Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295907 [TBL] [Abstract][Full Text] [Related]
60. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Wang Q; Shen X; Chen G; Du J Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]